Posts for the 'Birth Control' Category
Yaz / Yasmin Class Action vs. MDL Consolidation
A panel of judges ordered this week that all federal lawsuits over problems with Yaz and Yasmin birth control pills will be consolidated into an MDL, or multidistrict litigation, for pretrial proceedings in the Southern District of Illinois. Many people equate this with a Yaz / Yasmin class action, but each Yaz lawsuit or Yasmin lawsuit will remain an individual claim and if a settlement is not agreed upon during pretrial litigation, each plaintiff will still have a jury will determine the amount of damages they are entitled to in their case.
>>JPML LINK (PDF): Yasmin / Yaz MDL Order
Yasmin and Yaz Problems Highlighted by NY Times
An article in the New York Times over the weekend highlights the growing problems with Yaz and Yasmin birth control pills, which may have caused thousands of otherwise healthy young women to suffer serious and potentially life-threatening injuries, such as heart attacks, strokes, deep vein thrombosis (DVT), pulmonary embolism and gallbladder disease.
Yaz / Yasmin Attorneys Set for Hearing on Consolidation of Litigation
Tomorrow, attorneys representing women who have filed a lawsuit over Yaz and Yasmin problems will appear before the United States Judicial Panel on Multidistrict Litigation during hearings to determine whether all cases filed in federal district courts throughout the United States should be consolidated in an MDL for purposes of pretrial litigation.
Yasmin and Yaz Recall for Some Batches of Pills Could Be Coming?
The FDA released a warning letter this week sent to Bayer Pharmaceuticals over Yaz and Yasmin problems at the drug makers manufacturing plant in Germany. The letter indicates that Bayer hid out-of-specification test results for key ingredients in the birth control pills and said that several batches of the drugs should have never been released to the public. In what could be a forerunner to a Yasmin and Yaz recall, the FDA has asked for detailed lists of the batches shipped to U.S. customers.
>>FDA LINK: Warning Letter About Manufacturing Problems with Yaz and Yasmin
Yaz and Yasmin Blood Clot Risk
A study published yesterday in the British Medical Journal suggests that the risk of suffering a Yaz or Yasmin blood clot may be greater than with some other types of birth control pills and 6.3 times greater than taking no form of oral contraceptive.
Yaz and Yasmin Gallbladder Problems
In addition to the potential risk of serious and potentially life-threatening blood clots, many otherwise healthy young women who have used the birth control pill Yaz or Yasmin have experienced painful gallbladder problems that could ultimately require surgery for gallbladder removal.
>>MORE INFORMATION: Yaz Lawsuits
Yasmin / Yaz Class Action Lawsuit-Like Consolidation Sought
As is common in complex pharmaceutical claims, where a large number of people file lawsuits against a drug maker with similar allegations that an injury was caused by a side effect of a particular drug, plaintiffs are seeking to consolidate all Yasmin and Yaz birth control lawsuits in an MDL, or Multidistrict Litigation, where the individual cases would be assigned to one judge and handled in a manner similar to how a Yasmin / Yaz class action lawsuit would be managed during pretrial litigation.
Yasmin and Yaz Lawyers Reviewing Lawsuits
The lawyers at Saiontz & Kirk, P.A. are reviewing potential Yaz lawsuits and Yasmin lawsuits for women who have suffered severe heart injuries, blood clots, gallbladder disease or sudden death while taking the birth control pills. To review a potential claim for injury suffered by you, a friend or family member, request a free consultation and claim evaluation.
>>REVIEW A POTENTIAL LAWSUIT WITH OUR YAZ / YASMIN ATTORNEYS< <
Ortho Evra Recall Petition: Still No FDA Response
More than one year after the consumer advocacy group Public Citizen petitioned the FDA to issue an Ortho Evra recall, the birth control patch remains on the market and many healthy young women continue to be exposed to a risk of serious and potentially fatal blood clots, which could result in a heart attack, stroke, pulmonary embolism, deep vein thrombosis or other injury.
NuvaRing Lawyers Continue to Review Lawsuits for Failure to Warn of Blood Clots
Since the FDA approved NuvaRing birth control as a once-monthly vaginal contraceptive ring in October 2001, Organon USA has continued to provide inadequate and insufficient warnings about the risk of potentially life-threatening blood clots that may result in heart attacks, strokes, pulmonary embolism, deep vein thrombosis or death. The NuvaRing Lawyers at Saiontz & Kirk, P.A. are continuing to review potential failure to warn lawsuits for women who have experienced problems caused by the medication.
